We have located links that may give you full text access.
Frequency of renal pathology in Spain 1994-1999.
Nephrology, Dialysis, Transplantation 2002 September
BACKGROUND: There are not enough large epidemiological population-based studies of biopsy-proven nephropathies with detailed clinical and histopathological data.
METHODS: The Glomerulonephritis Registry of the Spanish Society of Nephrology has obtained data from 7016 patients with biopsied renal diseases between 1994 and 1999, investigating prevalence, incidence and clinical and histopathological data. Biopsies of transplant kidneys have not been considered.
RESULTS: The observed biopsy rate for all ages is 4.8 per 100 000 inhabitants. A male predominance is seen for all age groups. The most common clinical syndrome at any age is nephrotic syndrome. The prevalence of hypertension is higher in adults and elderly patients. The most common pathologies are IgA nephropathy, focal glomerulosclerosis, membranous nephropathy and lupus nephritis. The mean annual incidence (per million of population) of the most common nephropathies is IgA nephropathy 7.9, focal segmental glomerulosclerosis 6.4, membranous nephropathy 6.2, lupus nephritis 5.6, minimal-change disease 4.8, nephroangiosclerosis 4.6, vasculitis 4.3, membranoproliferative glomerulonephritis 3.6 and amyloidosis 3.3. In children, the most frequent causes are minimal-change disease, IgA nephropathy and focal glomerulosclerosis. In adults, the most common diagnoses are IgA nephropathy, lupus nephritis, and focal glomerulosclerosis. In elderly patients, the most frequently reported pathologies are vasculitis, membranous nephropathy and amyloidosis. Membranous nephropathy has increased in incidence in recent years.
CONCLUSIONS: We provide representative population-based descriptive data on native biopsy-proven renal diseases in Spain.
METHODS: The Glomerulonephritis Registry of the Spanish Society of Nephrology has obtained data from 7016 patients with biopsied renal diseases between 1994 and 1999, investigating prevalence, incidence and clinical and histopathological data. Biopsies of transplant kidneys have not been considered.
RESULTS: The observed biopsy rate for all ages is 4.8 per 100 000 inhabitants. A male predominance is seen for all age groups. The most common clinical syndrome at any age is nephrotic syndrome. The prevalence of hypertension is higher in adults and elderly patients. The most common pathologies are IgA nephropathy, focal glomerulosclerosis, membranous nephropathy and lupus nephritis. The mean annual incidence (per million of population) of the most common nephropathies is IgA nephropathy 7.9, focal segmental glomerulosclerosis 6.4, membranous nephropathy 6.2, lupus nephritis 5.6, minimal-change disease 4.8, nephroangiosclerosis 4.6, vasculitis 4.3, membranoproliferative glomerulonephritis 3.6 and amyloidosis 3.3. In children, the most frequent causes are minimal-change disease, IgA nephropathy and focal glomerulosclerosis. In adults, the most common diagnoses are IgA nephropathy, lupus nephritis, and focal glomerulosclerosis. In elderly patients, the most frequently reported pathologies are vasculitis, membranous nephropathy and amyloidosis. Membranous nephropathy has increased in incidence in recent years.
CONCLUSIONS: We provide representative population-based descriptive data on native biopsy-proven renal diseases in Spain.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
Perioperative echocardiographic strain analysis: what anesthesiologists should know.Canadian Journal of Anaesthesia 2024 April 11
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app